NADI-351
NADI-351 is a potent, orally bioavailable small molecule that selectively inhibits the Notch1 transcription complex, impeding its binding to target genes. It is used in cancer research for both in vitro mechanistic studies and in vivo models of Notch1-dependent malignancies.
Product Specifications
CAS Number
2503017-11-4
Smiles
C (\C) (=C/1\C (=O) N (CC (N (C) C) =O) C (=S) S1) /C2=CC (OC) =C (OCC=3NC=NN3) C (F) =C2
Molecular Formula
C19H20FN5O4S2
Molecular Weight
465.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
130527-ML750 100 µL
NR0B2 (Nuclear Receptor Subfamily 0 Group B Member 2, Orphan Nuclear Receptor SHP, Small Heterodimer Partner, SHP) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
LV782463 1.0 µg DNA
RPS6P8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details RC203314L2 10 µg
hnRNP A1 (HNRNPA1) (NM_002136) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details